Viscosupplementation Market Players:
- Sanofi S.A.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Anika Therapeutics, Inc.
- Seikagaku Corporation
- Smith & Nephew PLC
- Lifecore Biomedical, Inc.
- LG Chem Life Sciences Innovation Center, Inc.
- Fidia Farmaceutici S.p.A.
- F. Hoffmann-La Roche Ltd
- Chugai Pharmaceutical Co., Ltd.
- OrthogenRx, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of viscosupplementation is evaluated at USD 4.84 Billion.
The global viscosupplementation market size was worth around USD 4.55 Billion in 2025 and is set to register a CAGR of more than 7.2%, exceeding USD 9.12 Billion revenue by 2035.
North America’s viscosupplementation market will dominate over 40.70% share by 2035, fueled by high osteoarthritis cases and growing preference for short treatments.
Key players in the market include Sanofi S.A., Anika Therapeutics, Inc., Seikagaku Corporation, Smith & Nephew PLC, Lifecore Biomedical, Inc., LG Chem Life Sciences Innovation Center, Inc., Fidia Farmaceutici S.p.A., F. Hoffmann-La Roche Ltd, Chugai Pharmaceutical Co., Ltd., OrthogenRx, Inc.
